Nov 5 – Medical technology company Siemens Healthineers issued its fiscal 2027 outlook on Thursday after reporting fourth-quarter results as weakness in China continued to weigh on its diagnostics business.
The company expects fiscal 2027 comparable revenue growth of 4%-5% and adjusted basic earnings per share of 2.20 euros ($2.48) to 2.40 euros ($2.70).
• Fourth-quarter adjusted EBIT fell 2.0% to 1.077 billion euros from 1.098 billion euros a year earlier
• Fourth-quarter revenue rose 7.3% to 6.784 billion euros from 6.322 billion euros a year earlier
• Fourth-quarter diagnostics revenue fell 4.2% on a comparable basis to 1.067 billion euros
• Weakness in China remained a challenge, with diagnostics revenue in the region hurt by structural changes in the market environment
• China accounts for about 10% of group revenue and is Siemens Healthineers’ second-largest market after the US
• The German company will change its name to Healthineers as part of its planned spin-off from Siemens, which shareholders are due to vote on in February 2027
($1 = 0.8880 euros)
(Reporting by Kira Britten and Paolo Laudani, editing by Matt Scuffham)
Comments